Upling, a medical cannabis delivery app, is set to officially launch Bud-E, an AI integration designed to provide personalized cannabis recommendations. Bud-E aims to optimize cannabis infusion by combining personal health data, patient feedback, and genetic insights, transforming strain selection into a science-backed process.
Speaking to Colin Fraser, founder of the first Black-owned delivery-focused cannabis app, Bud-E functions as a precision medicine tool that analyzes a user's endocannabinoid system to match it with plant genetics, similar to 23andMe.
Currently in beta testing, Bud-E addresses user trust by offering survey options and community-curated recommendations. A full launch is planned for October. Colin developed the app and the idea for Bud-E after caring for his mother during her cancer diagnosis.